What is KPTI's dilution risk score?

KPTI has a latest available DilutionScore record of 74/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for KPTI, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for KPTI?

DilutionWatch tracks 25 SEC filing types for KPTI including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect KPTI shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For KPTI, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for KPTI tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for KPTI. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

KPTI Dilution Risk Score: 74/100 (HIGH)

Score Breakdown

📋 Offering Ability

80

💰 Cash Runway

40

📊 Float Risk

55

⚠️ Warrant Exposure

40

🔄 Convertible Debt

85

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 33%

🔁 Convertible Conversion model 60%

• Major convertible overhang: 66% potential dilution

• Convertible risk score very high (85/100)

📉 Score Deterioration model 10%

• Score in HIGH risk zone (74/100)

🔔 Track KPTI — Get forecast alerts →

Market Data

Market Cap$206.23M

Shares Outstanding22.68M

Float14.70M

Cash$148.40M

Debt$169.29M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 151.6% shares (2026Q1 vs prior)

84 institutional holders · 27.62M shares

#1 Ikarian Capital, LLC 2.57M shares

#2 Commodore Capital LP 1.95M shares

#3 RA CAPITAL MANAGEMENT, L.P. 1.92M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest7.56M

Days to Cover2.7

% of Float51.4%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30

xbrl XBRL CONVERTIBLE 2025-12-31

8-K 8K EVENT 2026-03-24

4 INSIDER TRANSACTION 2026-03-03

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual KPTI Dilution Snapshot

Karyopharm Therapeutics Inc. (KPTI) has a DilutionScore of 74/100, rated High dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for KPTI: xbrl on 2026-06-30; 8-K on 2026-03-24; 4 on 2026-03-03.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.